Citation
Di Zenzo, Giovanni, et al. "Multicenter Prospective Study of the Humoral Autoimmune Response in Bullous Pemphigoid." Clinical Immunology (Orlando, Fla.), vol. 128, no. 3, 2008, pp. 415-26.
Di Zenzo G, Thoma-Uszynski S, Fontao L, et al. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol. 2008;128(3):415-26.
Di Zenzo, G., Thoma-Uszynski, S., Fontao, L., Calabresi, V., Hofmann, S. C., Hellmark, T., Sebbag, N., Pedicelli, C., Sera, F., Lacour, J. P., Wieslander, J., Bruckner-Tuderman, L., Borradori, L., Zambruno, G., & Hertl, M. (2008). Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clinical Immunology (Orlando, Fla.), 128(3), 415-26. https://doi.org/10.1016/j.clim.2008.04.012
Di Zenzo G, et al. Multicenter Prospective Study of the Humoral Autoimmune Response in Bullous Pemphigoid. Clin Immunol. 2008;128(3):415-26. PubMed PMID: 18571472.
TY - JOUR
T1 - Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
AU - Di Zenzo,Giovanni,
AU - Thoma-Uszynski,Sybille,
AU - Fontao,Lionel,
AU - Calabresi,Valentina,
AU - Hofmann,Silke C,
AU - Hellmark,Thomas,
AU - Sebbag,Nathalie,
AU - Pedicelli,Cristina,
AU - Sera,Francesco,
AU - Lacour,Jean-Philippe,
AU - Wieslander,Jörgen,
AU - Bruckner-Tuderman,Leena,
AU - Borradori,Luca,
AU - Zambruno,Giovanna,
AU - Hertl,Michael,
Y1 - 2008/06/20/
PY - 2008/02/13/received
PY - 2008/04/28/revised
PY - 2008/04/29/accepted
PY - 2008/6/24/pubmed
PY - 2008/9/6/medline
PY - 2008/6/24/entrez
SP - 415
EP - 26
JF - Clinical immunology (Orlando, Fla.)
JO - Clin Immunol
VL - 128
IS - 3
N2 - Bullous pemphigoid (BP) is an autoimmune bullous disease, associated with autoantibodies directed against the hemidesmosomal components BP180 and BP230. In this study for the first time different laboratories have analyzed the autoantibody profile in the same group of 49 prospectively recruited BP patients. The results show that: 1) disease severity and activity correlated with levels of IgG against the BP180-NC16A domain, but also against a COOH-terminal epitope of BP180, 2) distinct epitopes of the BP180 ectodomain other than BP180-NC16A were recognized by 96% of the BP sera; and 3) the combined use of BP180 and BP230 ELISA led to the detection of IgG autoantibodies in all the BP sera. These results demonstrate the usefulness of the combined ELISAs based on various BP180 and BP230 fragments in establishing the diagnosis of BP and support the concept that BP180 is the major autoantigen of BP.
SN - 1521-7035
UR - https://www.unboundmedicine.com/medline/citation/18571472/Multicenter_prospective_study_of_the_humoral_autoimmune_response_in_bullous_pemphigoid_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1521-6616(08)00651-7
DB - PRIME
DP - Unbound Medicine
ER -